Question 1

What are the specific chemotherapy regimens I might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma clinical trial (NCT06831136). Contact the study team or your healthcare provider for specific answers.

Question 2

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma clinical trial (NCT06831136). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of pembrolizumab and the other treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma clinical trial (NCT06831136). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma clinical trial (NCT06831136). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I do not respond to the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma clinical trial (NCT06831136). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma clinical trial (NCT06831136). Contact the study team or your healthcare provider for specific answers.

What this study is about